Tuberculous pleural effusion

JA Shaw, AH Diacon, CFN Koegelenberg - Respirology, 2019 - Wiley Online Library
Tuberculous effusion is a common disease entity with a spectrum of presentations from a
largely benign effusion, which resolves completely, to a complicated effusion with …

Pulmonary TB and chronic pulmonary aspergillosis: clinical differences and similarities

JB Baluku, E Nuwagira, F Bongomin… - … of Tuberculosis and …, 2021 - ingentaconnect.com
BACKGROUND: Pulmonary TB (PTB) and chronic pulmonary aspergillosis (CPA) are both
progressive and debilitating parenchymal lung diseases with overlapping risk factors …

Биомаркеры и иммунологические тесты. Экспериментально-клинические параллели латентной туберкулезной инфекции

ДА Кудлай - Туберкулез и болезни легких, 2020 - tibl-journal.com
Аннотация В обзоре использовано 94 источника литературы. Описаны эксперименты,
проведенные на макаках Cynomolgus, по латентной туберкулезной инфекции …

Overview of ImageCLEF 2018: Challenges, datasets and evaluation

B Ionescu, H Müller, M Villegas… - Experimental IR Meets …, 2018 - Springer
This paper presents an overview of the ImageCLEF 2018 evaluation campaign, an event
that was organized as part of the CLEF (Conference and Labs of the Evaluation Forum) …

Immunometabolism during Mycobacterium tuberculosis infection

NC Howard, SA Khader - Trends in microbiology, 2020 - cell.com
Over a quarter of the world's population is infected with Mycobacterium tuberculosis (Mtb),
the causative agent of tuberculosis (TB). Approximately 3.4% of new and 18% of recurrent …

The application of artificial intelligence in the diagnosis and drug resistance prediction of pulmonary tuberculosis

S Liang, J Ma, G Wang, J Shao, J Li, H Deng… - Frontiers in …, 2022 - frontiersin.org
With the increasing incidence and mortality of pulmonary tuberculosis, in addition to tough
and controversial disease management, time-wasting and resource-limited conventional …

[HTML][HTML] Differentiating between drug-sensitive and drug-resistant tuberculosis with machine learning for clinical and radiological features

F Yang, H Yu, K Kantipudi, M Karki… - … Imaging in Medicine …, 2022 - ncbi.nlm.nih.gov
Background Tuberculosis (TB) drug resistance is a worldwide public health problem that
threatens progress made in TB care and control. Early detection of drug resistance is …

[HTML][HTML] Clinical features of pulmonary mucormycosis in patients with different immune status

M Peng, H Meng, Y Sun, Y Xiao, H Zhang… - Journal of thoracic …, 2019 - ncbi.nlm.nih.gov
Background Pulmonary mucormycosis (PM) is a relatively rare but often fatal and rapidly
progressive disease. Most studies of PM are case reports or case series with limited …

[HTML][HTML] Updates on 18F-FDG-PET/CT as a clinical tool for tuberculosis evaluation and therapeutic monitoring

WY Yu, PX Lu, M Assadi, XL Huang… - … Imaging in Medicine …, 2019 - ncbi.nlm.nih.gov
Tuberculosis (TB) is currently the world's leading cause of infectious mortality. The complex
immune response of the human body to Mycobacterium tuberculosis (M. tb) results in a wide …

Generalization challenges in drug-resistant tuberculosis detection from chest X-rays

M Karki, K Kantipudi, F Yang, H Yu, YXJ Wang, Z Yaniv… - Diagnostics, 2022 - mdpi.com
Classification of drug-resistant tuberculosis (DR-TB) and drug-sensitive tuberculosis (DS-
TB) from chest radiographs remains an open problem. Our previous cross validation …